SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board amended the 2026 Repurchase Program effective June 3, 2026, to impose a 45% voting power ownership cap on any single shareholder, materially constraining the Company's ability to execute its previously authorized $1.25 billion repurchase program.
View raw filing on EDGAR →The filing discloses a quarterly cash dividend declaration of $0.0625 per share by the Board of Directors. While dividend declarations are routine corporate actions, this disclosure in an 8-K Item 8.01 suggests the company views it as material to investors. However, it does not fit cleanly into any of the more specific event categories (earnings, executive changes, M&A, impairments, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The disclosure confirms full-year 2026 guidance and provides a Q2 update showing low-single-digit comparable store sales growth tracking, along with a repurchase program status update ($20M of $50M authorized repurchased). While guidance confirmation and operational updates are material to investors assessing company performance, this does not fit neatly into the specific event categories (not an earnings release, not a restatement, not an M&A event, etc.). The Item 7.01 Regulation FD Disclosure format and forward-looking nature of the guidance, combined with the operational update on e-commerce migration and comparable sales trends, warrant classification as a material event that does not fit the more specific taxonomy.
View raw filing on EDGAR →The filing discloses a dividend declaration of $9.96 per share, which is a material distribution to shareholders. While dividend declarations are routine for closed-end funds, this specific amount and the formal 8-K disclosure indicate materiality to investors. However, this does not fit cleanly into the standard taxonomy categories (it is not an earnings release, compensation arrangement, or other defined event type), warranting classification as "other_material."
View raw filing on EDGAR →The disclosure announces receipt of a $25–$30 million order from an existing customer, which is material in scale and would affect a reasonable investor's assessment of near-term revenue and business momentum. However, the filing does not fit neatly into the standard taxonomy (not an earnings release, M&A activity, or other defined event type), and the cautionary language about future deployment timing and market conditions introduces uncertainty about execution. This is best classified as other_material.
View raw filing on EDGAR →OPAL Fuels announced commencement of construction on two RNG facilities (50/50 joint venture with GFL Environmental) expected to produce 15 million gasoline gallon equivalents annually. This represents material capital deployment and expansion of the Company's RNG production and distribution infrastructure, which is central to its business strategy. While not a classic M&A transaction, the joint venture facility development and associated production capacity are material to investors assessing the Company's growth trajectory and operational scale.
View raw filing on EDGAR →Cardlytics effected a 1-for-10 reverse stock split and reduction in authorized shares, both approved by stockholders via Charter Amendment filed June 3, 2026. The reverse split is a material capital structure adjustment affecting share count and trading mechanics.
View raw filing on EDGAR →KeyCorp is recasting segment financial information in its 2025 Form 10-K to reflect a change in segment reporting implemented in Q1 2026, specifically the reallocation of centrally managed interest rate risk from Consumer Bank and Commercial Bank segments to the Other segment. While the company explicitly states this is "not an amendment or restatement" and there is "no impact on the Company's consolidated financial statements," the recast affects how segment results are presented and disclosed, which is material to investors evaluating business unit performance. The filing is required under SEC rules when a registrant makes accounting changes and subsequently files new registration or proxy statements incorporating prior period financials.
View raw filing on EDGAR →RadNet disclosed a proposed amendment to its First Lien Credit Agreement to add an incremental term loan of $200 million. While this represents a material financing event that would affect investor assessment of the company's capital structure and liquidity, it does not fit cleanly into the more specific categories (ma_activity applies to acquisitions/dispositions, dilutive_issuance to equity sales, covenant_breach to defaults). The amendment itself is a debt restructuring or refinancing activity that is material but lacks a dedicated taxonomy category.
View raw filing on EDGAR →The filing discloses a corporate update on "NYSE compliance process and strategic transaction initiatives" via press release. While the Item 7.01 disclosure itself is vague, the reference to NYSE compliance suggests potential delisting risk or listing status concerns, and "strategic transaction initiatives" suggests possible M&A activity. Without access to the full press release (Exhibit 99.1), the most appropriate classification is other_material, as the disclosure touches on material matters (compliance and transactions) but the specific nature and materiality cannot be fully determined from the Item text alone.
View raw filing on EDGAR →Cabaletta Bio disclosed clinical trial data and development updates for rese-cel across its autoimmune portfolio, including encouraging early preconditioning-free lupus findings and anticipated regulatory milestones (SSc registrational program initiation in 4Q26, DM/ASyS topline data in mid-2027, BLA submission in 2H27). For a clinical-stage biotech company, positive clinical trial results and development progress are material to investor assessment of pipeline value and regulatory prospects.
View raw filing on EDGAR →FortuneX Acquisition Corp consummated its IPO on May 26, 2026, raising $75 million in gross proceeds from 7.5 million units at $10.00 per unit, with simultaneous sponsor purchases of $2.975 million in private placement units. While this is a significant capital-raising event material to investors, it does not fit neatly into the standard taxonomy categories (earnings_release, ma_activity, dilutive_issuance). The disclosure is primarily informational about the IPO closing and trust account establishment rather than a forward-looking material event like a going concern or covenant breach. This is classified as other_material because it represents a transformational liquidity event for a SPAC that would affect investor assessment, but lacks a dedicated taxonomy category.
View raw filing on EDGAR →JCP&L announced an extension of its debt exchange offer covering $1.35 billion in aggregate principal amount of senior notes (4.150% due 2029, 4.400% due 2031, and 5.150% due 2036), extending the expiration from June 1 to June 15, 2026. While this involves refinancing activity and debt management, it does not fit cleanly into the more specific event categories (not an M&A transaction, not a covenant breach, not a restatement or impairment). The extension of a material debt exchange offer is material to investors assessing the registrant's capital structure and liquidity management, warranting disclosure under Item 8.01.
View raw filing on EDGAR →The disclosure announces a two-for-one forward stock split effected through an amendment to the Certificate of Incorporation, with a record date of June 25, 2026 and distribution on June 30, 2026. While stock splits are material corporate actions affecting share structure and investor holdings, they do not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or other defined event types). This is classified as other_material because it is a significant capital structure event that would affect a reasonable investor's assessment of share ownership and trading mechanics.
View raw filing on EDGAR →The Buckle announced a quarterly dividend of $0.35 per share, representing a material capital allocation decision affecting shareholder returns.
View raw filing on EDGAR →Arch Capital Group announced cash tender offers by its subsidiaries to repurchase up to $350 million in outstanding senior notes (5.144% notes due 2043 and 5.031% notes due 2046). While this is a material capital allocation and debt management activity that would affect investor assessment of the company's financial position and strategy, it does not fit cleanly into the more specific M&A or debt covenant categories—it is a voluntary debt repurchase program rather than a merger, acquisition, or covenant breach. This is best classified as other_material.
View raw filing on EDGAR →The filing discloses a press release dated June 2, 2026, under Item 8.01 (Other Events) but provides no substantive detail about the press release's content. Without access to Exhibit 99.1, the specific nature of the event cannot be determined. Given that Comcast is a major public company and the disclosure warrants an 8-K filing, the event is presumed material, but the event type cannot be reliably classified into a more specific category.
View raw filing on EDGAR →American Tower Corporation announced a partial redemption of €250 million of its €600 million outstanding 4.125% senior unsecured notes due 2027, with a redemption date of June 18, 2026. While this is a material debt management action affecting the company's capital structure and outstanding obligations, it does not fit neatly into the more specific event categories (covenant_breach, ma_activity, or material_impairment). The redemption is a routine debt reduction exercise executed within the contractual terms of the indenture, making "other_material" the most appropriate classification.
View raw filing on EDGAR →Rezolute issued a press release on June 2, 2026 announcing an interim update on its upLIFT study, a clinical trial. While the actual content of the update is not provided in this Item 7.01 disclosure (only boilerplate forward-looking statements and liability disclaimers are shown), interim clinical trial results can be material to investors assessing the company's pipeline and prospects. Without visibility into whether the update was positive, negative, or neutral, and lacking the substantive details, this is best classified as other_material rather than a more specific category.
View raw filing on EDGAR →The disclosure is a guidance update issued via press release on June 2, 2026, revising previously provided guidance from May 7, 2026 for Q2 and full-year fiscal 2026. While guidance updates can be material to investors, the filing does not disclose the specific nature, direction, or magnitude of the revision, making it difficult to classify as a standard earnings_release (which typically involves actual results) or fit cleanly into other defined categories. The materiality depends on the substance of the revision, which is not detailed in this Item 7.01 disclosure itself.
View raw filing on EDGAR →The disclosure reports receipt of approximately $28.7 million in warrant exercise proceeds in April-May 2026, increasing cash from $107.1 million to approximately $135.8 million, and notes 196.6 million shares outstanding as of June 2, 2026. While warrant exercises are a form of dilutive issuance, the filing emphasizes the cash proceeds and liquidity position rather than the equity issuance mechanics, and does not clearly indicate this was a private placement or PIPE transaction. The material cash infusion and updated share count are relevant to investor assessment, but the event does not fit cleanly into the dilutive_issuance category (which typically covers unregistered private placements) or any other specific taxonomy item.
View raw filing on EDGAR →The Board declared a cash distribution of $0.31 per share, which is a material capital allocation decision affecting shareholders. While routine dividend declarations are sometimes not considered material, the specific disclosure in an 8-K Item 8.01 and the per-share amount suggest this is a significant distribution event. However, this does not fit cleanly into the more specific event categories (it is not an earnings release, executive action, M&A, impairment, or other defined event type), so "other_material" is the most appropriate classification.
View raw filing on EDGAR →The Company designated 1,000,000 shares of Series C Convertible Preferred Stock via Articles Supplementary, materially modifying the capital structure and imposing distribution restrictions on junior and parity securities.
View raw filing on EDGAR →TXNM Energy's subsidiaries disclosed significant regulatory filings: TNMP's comprehensive settlement in a base rate review before the PUCT and PNM's application for approval of carbon-free generation resources. These regulatory matters are material to investors assessing the company's regulatory environment and future earnings.
View raw filing on EDGAR →The Company entered into a Third Amendment to its Shareholders Rights Agreement on June 2, 2026, eliminating the 'Acting in Concert' defined term while retaining other anti-takeover protections. This governance amendment affects shareholder assessment of takeover risk and Board authority.
View raw filing on EDGAR →The disclosure announces alignment with the FDA on a revised, earlier ORIGIN 3 eGFR analysis plan for atacicept in IgA Nephropathy, with results expected in Q3 2026 and a planned supplemental BLA submission in Q4 2026. This represents a material regulatory milestone and timeline acceleration for a key clinical program, but does not fit neatly into the more specific event categories (it is neither a completed M&A transaction, a restatement, an executive change, nor a cybersecurity incident). The forward-looking nature and regulatory significance make it material to investors assessing the company's pipeline progress.
View raw filing on EDGAR →MannKind announced FDA approval of Afrezza for pediatric use (ages 6+) on May 29, 2026, and completion of the last remaining postmarketing requirement from the original 2014 approval. This regulatory milestone expands the addressable market to over 350,000 children and adolescents with diabetes in the U.S. and removes a material regulatory constraint. While this is a positive development, it does not fit neatly into the more specific event categories (not an earnings release, M&A, impairment, or litigation); it is best classified as a material regulatory/product approval event.
View raw filing on EDGAR →Virgin Galactic disclosed a material debt redemption strategy involving the early redemption of approximately $30.5 million in principal of 9.80% First Lien Notes due 2028, to be paid via equity issuance rather than cash. While this is a capital management action rather than a traditional covenant breach or going-concern disclosure, the early redemption of a substantial portion of near-term debt obligations—coupled with the company's stated need to "improve liquidity" and "enhance financial flexibility" ahead of commercial operations—signals material financial restructuring that would affect a reasonable investor's assessment of the company's financial position and cash runway.
View raw filing on EDGAR →The Company disposed of its entire exposure in Work Genius Holdings, Inc. and Work Genius, LLC for approximately $10.3 million on May 27, 2026. While this represents a disposition of an investment position, it is disclosed under Item 7.01 (Regulation FD Disclosure / Other Events) rather than Item 1.02 or 2.01 (which typically govern material acquisitions and dispositions). The materiality of a $10.3 million disposition for a BDC warrants disclosure, but the Item 7.01 treatment and lack of language indicating this is a "material acquisition or disposition" under Regulation 8-K suggests this may be a significant but non-controlling investment exit rather than a transaction meeting the formal M&A threshold. Classified as other_material given the ambiguity between investment disposition and formal M&A activity.
View raw filing on EDGAR →This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt details. This does not fit cleanly into covenant_breach (no violation alleged) or the more specific debt-related categories, making other_material the most appropriate classification for this regulatory debt disclosure.
View raw filing on EDGAR →JPMorgan Chase closed a $500 million public offering of Fixed-to-Floating Rate Notes due 2030 on June 2, 2026, as an additional issuance to a prior $2.75 billion offering from April 2026. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit neatly into the more specific event categories (it is registered debt, not a dilutive equity issuance under Item 3.02, and not an M&A transaction). This is classified as other_material because it represents a significant financing event disclosed under Item 8.01.
View raw filing on EDGAR →TETRA Technologies disclosed material strategic initiatives including board approval of the final investment decision for the Arkansas Bromine Project with $220 million remaining capex and Phase 2 underway (expected 2028 operation), and a new joint venture with Magrathea Metals for magnesium production.
View raw filing on EDGAR →Primerica amended and restated its $200 million revolving credit facility on June 2, 2026, extending the maturity date to June 2, 2031, modifying the Applicable Margin, and adjusting financial covenants. This refinancing demonstrates the company's ability to secure credit and extends its liquidity runway.
View raw filing on EDGAR →The filing discloses a distribution declaration by a BDC (Business Development Company) for both Class I and Class S common shares, with specific per-share amounts ($0.1191 and $0.1077 net, respectively) payable on June 18, 2026. While distributions are routine for BDCs and do not fit the earnings_release category (which typically involves comprehensive financial results), this material distribution announcement affects shareholder value and would be relevant to investors. The disclosure does not match any more specific event type in the taxonomy, making other_material the most appropriate classification.
View raw filing on EDGAR →Senior Credit Investments declared a cash distribution of $17.0106 per Unit to unitholders, payable June 18, 2026. While distributions are routine for investment companies and funds, the specific dollar amount and timing would be material to unitholders assessing returns and cash flow. This does not fit neatly into earnings_release (no financial results disclosed) or other specific event types, making other_material the most appropriate classification.
View raw filing on EDGAR →The Company disclosed an updated feasibility study for its Grassy Mountain Gold Project prepared under Regulation S-K subpart 1300, which is a material technical and economic assessment of a major mineral property. While this does not fit neatly into the standard 8-K event categories (not an earnings release, M&A activity, or impairment charge), an updated feasibility study for a 100%-owned project would materially affect investor assessment of the Company's asset value and development prospects, warranting disclosure as a material event.
View raw filing on EDGAR →Avista entered into a non-binding MOU with a developer for a large load electric service project representing 125 MW initially (expandable to 500 MW by 2032) in its Washington service territory. While the MOU is non-binding and subject to regulatory approval and definitive agreements, the scale of the potential load (500 MW) and the multi-year commitment pathway (2029–2032) represent material business development activity that would affect investor assessment of the company's growth prospects and capital requirements. This does not fit neatly into the M&A taxonomy (no acquisition or merger) but is a material commercial commitment warranting disclosure.
View raw filing on EDGAR →The disclosure describes the consummation of a $80 million IPO and concurrent $2.52 million private placement by a SPAC (Burtech Acquisition Corp II), with proceeds deposited in trust. While this is a capital-raising event material to investors, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is the company's own IPO rather than an acquisition or secondary offering. The event is material but best classified as "other_material" given the SPAC structure and trust account mechanics.
View raw filing on EDGAR →The disclosure describes the consummation of Breeze Acquisition Corp. II's IPO on May 14, 2026, generating $140 million in gross proceeds from 14 million units (including over-allotment), plus a concurrent private placement of 470,000 units for $4.7 million. While this is a significant capital-raising event material to investors, it does not fit neatly into the standard 8-K taxonomy—it is neither an earnings release, M&A activity, nor a traditional executive or governance event. The IPO itself is the material event, but the taxonomy lacks a dedicated "IPO" or "capital_raising" category, making "other_material" the most appropriate classification.
View raw filing on EDGAR →Bluejay Diagnostics entered into a material definitive agreement with Argonaut Manufacturing Services on May 27, 2026, for comprehensive manufacturing services supporting the Company's Symphony™ platform and IL-6 testing products, including planning, engineering, supply chain management, formulation, filling, quality control, and distribution.
View raw filing on EDGAR →The disclosure reports Bitcoin production metrics from a newly acquired subsidiary (CS Digital Ventures, LLC, acquired May 28, 2026) and describes hosting arrangements and operational outlook. While the acquisition itself would typically be classified as ma_activity, this Item 7.01 disclosure focuses on operational metrics and production reporting rather than the acquisition transaction itself. The material nature stems from the recent acquisition and its contribution to the company's operations, but the primary content is operational disclosure under Regulation FD rather than a discrete M&A event announcement.
View raw filing on EDGAR →INmune Bio announced exploratory chi-separation MRI imaging results from the Phase 2 MINDFuL clinical trial of XPro1595 in early Alzheimer's disease patients. While this is a clinical trial result disclosure, it does not fit the standard "earnings_release" category (which typically covers quarterly/annual financial results) and appears to be a material clinical development update that would affect investor assessment of the company's pipeline progress. Classified as other_material given the clinical-stage nature of the disclosure and its significance to a biotech company's valuation.
View raw filing on EDGAR →The section header indicates Item 5.02 disclosure covering departures, elections, appointments, and/or compensatory arrangements, but the actual prose content was not provided. Without the specific details of what occurred (e.g., whether an executive departed, was appointed, received compensation, or some combination), I cannot reliably classify this into a more specific event type. I am marking it as material because Item 5.02 disclosures typically involve material executive changes, but the confidence is low due to missing content.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligations (debt securities) by the Federal Home Loan Bank of San Francisco. Schedule A details a $10 million fixed-rate bond (CUSIP 3130BAXB8) with a 4.25% coupon, maturing 6/04/2031, traded on 5/29/2026. While Item 2.03 is the designated item for creation of direct financial obligations, the filing itself notes that "consolidated obligations issuance is material to the Bank" and the Bank has not made materiality judgments on particular issuances. This represents a routine debt issuance by a Federal Home Loan Bank, which is material to the institution's capital structure but is a standard operational activity for such entities. The event does not fit neatly into more specific categories (not M&A, not a covenant breach, not a restatement), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature, explaining the mechanics and joint-and-several structure of FHLB debt rather than announcing a specific new obligation event. The absence of a Schedule A with specific issuance details and the boilerplate nature of the disclosure suggest this is a routine periodic reporting of the Bank's debt issuance framework rather than a discrete material event triggering Item 2.03.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligations (debt securities) totaling approximately $170 million across five tranches with trade dates of 05/27/2026 and 05/29/2026. While Item 2.03 is technically titled "Creation of a Direct Financial Obligation," the filing itself states "although consolidated obligations issuance is material to the FHLBank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine debt issuance reporting for a Federal Home Loan Bank, not a covenant breach, going-concern issue, or other acute financial stress signal. However, the creation of direct financial obligations of this magnitude is material to investors assessing the registrant's capital structure and leverage, warranting classification as a material event that does not fit the more specific taxonomy categories.
View raw filing on EDGAR →GameStop's Board approved a new $2.0 billion share repurchase authorization, replacing the previous authorization, signaling the company's capital allocation strategy.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of Consolidated Obligations (debt securities) totaling approximately $3.795 billion across multiple bond and note issuances with trade dates of 5/27–5/28/2026. While Item 2.03 is technically designed for "creation of a direct financial obligation," the filing itself explicitly states that "although Consolidated Obligations issuance is material to the FHLB, we have not made a judgment as to the materiality of any particular Consolidated Obligation or Obligations." The registrant's own caveat and the routine nature of debt issuance for a Federal Home Loan Bank (whose primary business is funding through capital markets) suggest this is a material but routine disclosure that does not fit cleanly into the more specific event categories (e.g., not a covenant breach, not a going-concern issue, not a restatement). The scale of issuance ($3.795B) is material to investors, but the disclosure is administrative in character.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligation bonds totaling $120 million across four tranches (maturing 2029–2037 with coupons of 4.25%–5.25%), which are material funding activities for a Federal Home Loan Bank. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the event does not fit cleanly into the standard taxonomy: it is neither a traditional debt covenant breach (Item 2.04) nor a discrete M&A or capital-raising event (dilutive_issuance applies to equity, not debt). The disclosure is routine for a wholesale funding institution but material to investors assessing the Bank's capital structure and funding costs.
View raw filing on EDGAR →This Item 2.03 disclosure reports the issuance of consolidated obligations (bonds and discount notes) totaling approximately $2.5 billion across multiple tranches with varying maturities and rate structures. While Item 2.03 typically signals covenant breaches or direct financial obligations under distress, this filing discloses routine debt issuances by a Federal Home Loan Bank in the ordinary course of funding operations. The disclosure is material to investors as it reflects significant new debt obligations, but the event itself—scheduled debt issuance—does not fit cleanly into the more specific event categories (covenant_breach implies financial stress; ma_activity implies acquisition/disposition). The Bank explicitly notes that "although certain aggregated issuances of consolidated obligations are material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation," suggesting this is standard periodic reporting of debt activity rather than a triggering financial event.
View raw filing on EDGAR →